Browsing Category

64387 posts
Ministry of Tourism and Creative Economy of the Republic of Indonesia proudly present Wonderful Indonesia in India

Ministry of Tourism and Creative Economy of the Republic of Indonesia proudly present Wonderful Indonesia in India

NEW DELHI, Feb. 19, 2024 /PRNewswire/ — Following successful tourism promotion in…
SIBIONICS Announced to Exhibit at the 17th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD)

SIBIONICS Announced to Exhibit at the 17th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD)

The company will be hosting an influencer meeting during the conference LOS…
Xinhua Silk Road: Chinese baijiu brand enlivens foreign Spring Festival celebrations as symbol of "harmonious happiness"

Xinhua Silk Road: Chinese baijiu brand enlivens foreign Spring Festival celebrations as symbol of "harmonious happiness"

BEIJING, Feb. 19, 2024 /PRNewswire/ — Wuliangye, a reputed Chinese baijiu brand,…
Zetrix and Web3Labs launch Zetrix Global Accelerator Programme

Zetrix and Web3Labs launch Zetrix Global Accelerator Programme

Seeks Approval for Ecosystem ETFs PETALING JAYA, Malaysia, Feb. 19, 2024 /PRNewswire/ —…
NEXTGEN and Claroty team up with a new distribution agreement to boost regional growth into Singapore, Indonesia and Philippines

NEXTGEN and Claroty team up with a new distribution agreement to boost regional growth into Singapore, Indonesia and Philippines

SINGAPORE, Feb. 19, 2024 /PRNewswire/ — NEXTGEN Group Asia and Claroty, the…
Xinhua Silk Road: E. China's coastal city celebrates lunar new year with cultural activities

Xinhua Silk Road: E. China's coastal city celebrates lunar new year with cultural activities

BEIJING, Feb. 19, 2024 /PRNewswire/ — During this Spring Festival season, scenic…
AffaMed Therapeutics Announces New Drug Application Acceptance by Singapore Health Sciences Authority (HSA) for DEXTENZA® for Treatment of Ocular Inflammation and Pain Following Ophthalmic Surgery, and Ocular Itching Associated with Allergic Conjunctivitis

AffaMed Therapeutics Announces New Drug Application Acceptance by Singapore Health Sciences Authority (HSA) for DEXTENZA® for Treatment of Ocular Inflammation and Pain Following Ophthalmic Surgery, and Ocular Itching Associated with Allergic Conjunctivitis

SHANGHAI, Feb. 19, 2024 /PRNewswire/ — AffaMed Therapeutics ("AffaMed"), a biotechnology company…
TECNO SPARK 20 Pro+ Picks Up Dual Prestigious French Design Awards 2024

TECNO SPARK 20 Pro+ Picks Up Dual Prestigious French Design Awards 2024

HONG KONG, Feb. 19, 2024 /PRNewswire/ — The SPARK 20 Pro+ from…